JP2004536046A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004536046A5 JP2004536046A5 JP2002578971A JP2002578971A JP2004536046A5 JP 2004536046 A5 JP2004536046 A5 JP 2004536046A5 JP 2002578971 A JP2002578971 A JP 2002578971A JP 2002578971 A JP2002578971 A JP 2002578971A JP 2004536046 A5 JP2004536046 A5 JP 2004536046A5
- Authority
- JP
- Japan
- Prior art keywords
- acne
- pharmaceutical composition
- tetracycline
- administered
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010000496 acne Diseases 0.000 claims 31
- 208000002874 Acne Vulgaris Diseases 0.000 claims 30
- 239000004098 Tetracycline Substances 0.000 claims 19
- 229960002180 tetracycline Drugs 0.000 claims 19
- 235000019364 tetracycline Nutrition 0.000 claims 19
- 229930101283 tetracycline Natural products 0.000 claims 19
- -1 bisphosphonate compound Chemical class 0.000 claims 17
- 239000008194 pharmaceutical composition Substances 0.000 claims 17
- 229910052739 hydrogen Inorganic materials 0.000 claims 11
- 239000001257 hydrogen Substances 0.000 claims 11
- 230000003115 biocidal effect Effects 0.000 claims 6
- 210000002966 serum Anatomy 0.000 claims 6
- SGKRLCUYIXIAHR-AKNGSSGZSA-N (4s,4ar,5s,5ar,6r,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1=CC=C2[C@H](C)[C@@H]([C@H](O)[C@@H]3[C@](C(O)=C(C(N)=O)C(=O)[C@H]3N(C)C)(O)C3=O)C3=C(O)C2=C1O SGKRLCUYIXIAHR-AKNGSSGZSA-N 0.000 claims 5
- 229960003722 doxycycline Drugs 0.000 claims 5
- FFTVPQUHLQBXQZ-KVUCHLLUSA-N (4s,4as,5ar,12ar)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1C2=C(N(C)C)C=CC(O)=C2C(O)=C2[C@@H]1C[C@H]1[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]1(O)C2=O FFTVPQUHLQBXQZ-KVUCHLLUSA-N 0.000 claims 4
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims 4
- 229960004023 minocycline Drugs 0.000 claims 4
- 150000003522 tetracyclines Chemical class 0.000 claims 4
- 150000002431 hydrogen Chemical class 0.000 claims 3
- 230000001937 non-anti-biotic effect Effects 0.000 claims 3
- XCCHQGIGHCRZOS-KBKZQPOHSA-N (4as,5as,6s,12ar)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical compound C1=CC=C2[C@@](C)(O)[C@@H](C[C@@H]3[C@](C(O)=C(C(N)=O)C(=O)C3)(O)C3=O)C3=C(O)C2=C1O XCCHQGIGHCRZOS-KBKZQPOHSA-N 0.000 claims 2
- 229940122361 Bisphosphonate Drugs 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 239000003242 anti bacterial agent Substances 0.000 claims 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims 2
- MWUTTXATIMURBN-VSAOOKSHSA-N (4aS,5aS,6S,12aR)-3,6,10,11-tetrahydroxy-6-methyl-1,12-dioxo-4a,5,5a,12a-tetrahydro-4H-tetracene-2-carboxamide Chemical compound C[C@]1(O)[C@H]2C[C@H]3CC(O)=C(C(N)=O)C(=O)[C@H]3C(=O)C2=C(O)c2c(O)cccc12 MWUTTXATIMURBN-VSAOOKSHSA-N 0.000 claims 1
- NBRQRXRBIHVLGI-OWXODZSWSA-N (4as,5ar,12ar)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1C2=CC=CC(O)=C2C(O)=C(C2=O)[C@@H]1C[C@@H]1[C@@]2(O)C(O)=C(C(=O)N)C(=O)C1 NBRQRXRBIHVLGI-OWXODZSWSA-N 0.000 claims 1
- GUXHBMASAHGULD-SEYHBJAFSA-N (4s,4as,5as,6s,12ar)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1([C@H]2O)=C(Cl)C=CC(O)=C1C(O)=C1[C@@H]2C[C@H]2[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]2(O)C1=O GUXHBMASAHGULD-SEYHBJAFSA-N 0.000 claims 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims 1
- 208000003911 Acne Keloid Diseases 0.000 claims 1
- 206010000503 Acne cystic Diseases 0.000 claims 1
- 206010000513 Acne pustular Diseases 0.000 claims 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 1
- 208000001348 Chloracne Diseases 0.000 claims 1
- 206010011732 Cyst Diseases 0.000 claims 1
- FMTDIUIBLCQGJB-UHFFFAOYSA-N Demethylchlortetracyclin Natural products C1C2C(O)C3=C(Cl)C=CC(O)=C3C(=O)C2=C(O)C2(O)C1C(N(C)C)C(O)=C(C(N)=O)C2=O FMTDIUIBLCQGJB-UHFFFAOYSA-N 0.000 claims 1
- 206010051651 Dermatitis papillaris capillitii Diseases 0.000 claims 1
- 206010027026 Mechanical acne Diseases 0.000 claims 1
- 239000004100 Oxytetracycline Substances 0.000 claims 1
- 206010033733 Papule Diseases 0.000 claims 1
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 claims 1
- 208000024780 Urticaria Diseases 0.000 claims 1
- 206010047623 Vitamin C deficiency Diseases 0.000 claims 1
- 210000001193 acne keloid Anatomy 0.000 claims 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 1
- 229910052794 bromium Inorganic materials 0.000 claims 1
- CYDMQBQPVICBEU-UHFFFAOYSA-N chlorotetracycline Natural products C1=CC(Cl)=C2C(O)(C)C3CC4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-UHFFFAOYSA-N 0.000 claims 1
- CYDMQBQPVICBEU-XRNKAMNCSA-N chlortetracycline Chemical compound C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-XRNKAMNCSA-N 0.000 claims 1
- HISOCSRUFLPKDE-KLXQUTNESA-N cmt-2 Chemical compound C1=CC=C2[C@](O)(C)C3CC4C(N(C)C)C(O)=C(C#N)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O HISOCSRUFLPKDE-KLXQUTNESA-N 0.000 claims 1
- VCROZLOYPNVPSH-DCKQLXEASA-N cmt-5 Chemical compound N1N=C2C3=C(O)C=CC=C3[C@@](C)(O)C3C2=C1[C@]1(O)C(=O)C(C(N)=O)=C(O)CC1C3 VCROZLOYPNVPSH-DCKQLXEASA-N 0.000 claims 1
- BVFDLIAWTKFZQD-JXVDNWKRSA-N cmt-8 Chemical compound O=C1C2=C(O)C=CC=C2C(C)[C@@H]2C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)C[C@@H]1C2O BVFDLIAWTKFZQD-JXVDNWKRSA-N 0.000 claims 1
- 239000002537 cosmetic Substances 0.000 claims 1
- 208000031513 cyst Diseases 0.000 claims 1
- 229960002398 demeclocycline Drugs 0.000 claims 1
- 239000003599 detergent Substances 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 238000010255 intramuscular injection Methods 0.000 claims 1
- 239000007927 intramuscular injection Substances 0.000 claims 1
- 238000010253 intravenous injection Methods 0.000 claims 1
- 229910052740 iodine Inorganic materials 0.000 claims 1
- 239000011630 iodine Substances 0.000 claims 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 1
- 229960000625 oxytetracycline Drugs 0.000 claims 1
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 claims 1
- 235000019366 oxytetracycline Nutrition 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 235000019260 propionic acid Nutrition 0.000 claims 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims 1
- 201000004700 rosacea Diseases 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 208000010233 scurvy Diseases 0.000 claims 1
- 238000007920 subcutaneous administration Methods 0.000 claims 1
- 238000013268 sustained release Methods 0.000 claims 1
- 239000012730 sustained-release form Substances 0.000 claims 1
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 claims 1
- 238000011200 topical administration Methods 0.000 claims 1
- 231100000331 toxic Toxicity 0.000 claims 1
- 230000002588 toxic effect Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28191601P | 2001-04-05 | 2001-04-05 | |
| PCT/US2002/010747 WO2002080932A1 (en) | 2001-04-05 | 2002-04-05 | Methods of treating acne |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009280436A Division JP2010053155A (ja) | 2001-04-05 | 2009-12-10 | ざ瘡の治療方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004536046A JP2004536046A (ja) | 2004-12-02 |
| JP2004536046A5 true JP2004536046A5 (enExample) | 2005-12-22 |
Family
ID=23079310
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002578971A Pending JP2004536046A (ja) | 2001-04-05 | 2002-04-05 | ざ瘡の治療方法 |
| JP2009280436A Pending JP2010053155A (ja) | 2001-04-05 | 2009-12-10 | ざ瘡の治療方法 |
| JP2011115785A Pending JP2011168613A (ja) | 2001-04-05 | 2011-05-24 | ざ瘡の治療方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009280436A Pending JP2010053155A (ja) | 2001-04-05 | 2009-12-10 | ざ瘡の治療方法 |
| JP2011115785A Pending JP2011168613A (ja) | 2001-04-05 | 2011-05-24 | ざ瘡の治療方法 |
Country Status (12)
| Country | Link |
|---|---|
| EP (4) | EP1716856A3 (enExample) |
| JP (3) | JP2004536046A (enExample) |
| KR (1) | KR100926326B1 (enExample) |
| AT (1) | ATE330615T1 (enExample) |
| AU (1) | AU2002303250B2 (enExample) |
| CA (2) | CA2440472C (enExample) |
| DE (1) | DE60212613T2 (enExample) |
| DK (1) | DK1383508T3 (enExample) |
| ES (1) | ES2266499T3 (enExample) |
| NZ (1) | NZ528197A (enExample) |
| PT (1) | PT1383508E (enExample) |
| WO (1) | WO2002080932A1 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2311796A1 (en) * | 2002-01-08 | 2011-04-20 | Paratek Pharmaceuticals, Inc. | 4-dedimethylamino tetracycline compounds |
| US8192749B2 (en) | 2003-04-16 | 2012-06-05 | Galderma Laboratories Inc. | Methods of simultaneously treating ocular rosacea and acne rosacea |
| WO2003088906A2 (en) * | 2002-04-16 | 2003-10-30 | Collagenex Pharmaceuticals, Inc. | Methods of simultaneously treating ocular rosacea and acne rosacea |
| WO2004091483A2 (en) | 2003-04-07 | 2004-10-28 | Shire Laboratories, Inc. | Once daily formulations of tetracyclines |
| WO2005011707A1 (en) | 2003-07-25 | 2005-02-10 | Warner Chilcott Company, Inc. | A doxycycline metal complex in a solid dosage form |
| WO2005046618A2 (en) * | 2003-11-06 | 2005-05-26 | Research Foundation Of State University Of New York, The | Methods of treating eczema |
| US7541347B2 (en) | 2007-04-02 | 2009-06-02 | Medicis Pharmaceutical Coropration | Minocycline oral dosage forms for the treatment of acne |
| US7544373B2 (en) | 2007-04-02 | 2009-06-09 | Medicis Pharmaceutical Corporation | Minocycline oral dosage forms for the treatment of acne |
| US8252776B2 (en) | 2007-04-02 | 2012-08-28 | Medicis Pharmaceutical Corporation | Minocycline oral dosage forms for the treatment of acne |
| US7919483B2 (en) * | 2005-06-24 | 2011-04-05 | Medicis Pharmaceutical Corporation | Method for the treatment of acne |
| US7704959B2 (en) * | 2006-10-03 | 2010-04-27 | Dow Pharmaceutical Sciences | Azithromycin for the treatment of nodular acne |
| JP5395052B2 (ja) * | 2007-03-23 | 2014-01-22 | モレキュラー リサーチ センター インコーポレイテッド | 炎症を処置するための組成物および方法 |
| WO2008121107A1 (en) * | 2007-04-02 | 2008-10-09 | Medicis Pharmaceutical Corporation | Minocycline oral dosage forms for the treatment of acne |
| AU2009248046B2 (en) * | 2008-05-16 | 2014-07-17 | Galderma Research & Development | Therapy regimen for treating acne related diseases |
| WO2010017310A1 (en) | 2008-08-06 | 2010-02-11 | Medicis Pharmaceutical Corporation | Method for the treatment of acne and certain dosage forms thereof |
| US9561241B1 (en) | 2011-06-28 | 2017-02-07 | Medicis Pharmaceutical Corporation | Gastroretentive dosage forms for minocycline |
| JP2015516971A (ja) * | 2012-04-19 | 2015-06-18 | ガルデルマ エス．アー． | ざ瘡の処置方法 |
| RU2557991C1 (ru) * | 2014-05-19 | 2015-07-27 | Вячеслав Владимирович Чеботарёв | Способ лечения больных вульгарными угрями (акне), страдающих дисплазией соединительной ткани |
| CO2017001953A1 (es) * | 2017-02-27 | 2018-08-31 | Corporacion Univ Lasallista | Método de encapsulación de tetraciclinas |
| JP2020527607A (ja) * | 2017-07-21 | 2020-09-10 | アルミラール・リミテッド・ライアビリティ・カンパニーＡｌｍｉｒａｌｌ， Ｌｌｃ | 非炎症性病変の処置 |
| BR112020013789A2 (pt) * | 2018-01-07 | 2021-02-17 | Dr. Reddy's Laboratories Ltd. | métodos para o tratamento de afecções cutâneas inflamatórias |
| US12208123B2 (en) | 2019-01-04 | 2025-01-28 | Dermata Therapeutics, Inc. | Compositions and methods for the treatment of skin conditions |
| WO2021215405A1 (ja) * | 2020-04-20 | 2021-10-28 | 国立大学法人大阪大学 | 免疫賦活化剤、及び治療又は予防用組成物 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1983000628A1 (en) * | 1981-08-27 | 1983-03-03 | Bernstein, Joel, E. | A method of treating acne vulgaris and composition containing carbamide peroxide |
| US5122519A (en) * | 1989-06-27 | 1992-06-16 | American Cyanamid Company | Stable, cosmetically acceptable topical gel formulation and method of treatment for acne |
| ATE194492T1 (de) * | 1990-08-16 | 2000-07-15 | Bloom Leonard | Topische behandlung von blepharitis |
| US5674539A (en) * | 1994-12-09 | 1997-10-07 | Tomas; Robert E. | Method of treating skin and composition |
| FR2730930B1 (fr) * | 1995-02-27 | 1997-04-04 | Oreal | Utilisation d'inhibiteurs de no-synthase pour diminuer l'effet irritant cutane de produits utilises dans le domaine cosmetique ou pharmaceutique |
| US5827840A (en) * | 1996-08-01 | 1998-10-27 | The Research Foundation Of State University Of New York | Promotion of wound healing by chemically-modified tetracyclines |
| US5789395A (en) * | 1996-08-30 | 1998-08-04 | The Research Foundation Of State University Of New York | Method of using tetracycline compounds for inhibition of endogenous nitric oxide production |
| US5908838A (en) * | 1998-02-19 | 1999-06-01 | Medics Pharmaceutical Corporation | Method for the treatment of acne |
| US6432934B1 (en) * | 1998-08-06 | 2002-08-13 | Advanced Vision Research | Methods and compositions for topical treatment of eye surface inflammation and related dry eye disease |
| US6015804A (en) * | 1998-09-11 | 2000-01-18 | The Research Foundation Of State University Of New York | Method of using tetracycline compounds to enhance interleukin-10 production |
| CA2343038A1 (en) * | 1998-09-28 | 2000-04-06 | Maria Emanuel Ryan | A novel inhibitor of cataract formation |
| US5998390A (en) * | 1998-09-28 | 1999-12-07 | The Research Foundation Of State University Of New York | Combination of bisphosphonate and tetracycline |
| WO2000028983A1 (en) * | 1998-11-18 | 2000-05-25 | Collagenex Pharmaceuticals, Inc. | Novel 4-dedimethy laminotetra cycline derivatives |
| JP2001072660A (ja) * | 1999-09-08 | 2001-03-21 | Welfide Corp | ＴＮＦ−α産生抑制剤および／またはＩＬ−１０産生促進剤 |
-
2002
- 2002-04-05 NZ NZ528197A patent/NZ528197A/en not_active IP Right Cessation
- 2002-04-05 AT AT02731267T patent/ATE330615T1/de active
- 2002-04-05 DE DE60212613T patent/DE60212613T2/de not_active Expired - Lifetime
- 2002-04-05 CA CA2440472A patent/CA2440472C/en not_active Expired - Lifetime
- 2002-04-05 EP EP06076250A patent/EP1716856A3/en not_active Withdrawn
- 2002-04-05 CA CA2719162A patent/CA2719162C/en not_active Expired - Lifetime
- 2002-04-05 PT PT02731267T patent/PT1383508E/pt unknown
- 2002-04-05 KR KR1020037012965A patent/KR100926326B1/ko not_active Expired - Lifetime
- 2002-04-05 AU AU2002303250A patent/AU2002303250B2/en not_active Expired
- 2002-04-05 EP EP10159154A patent/EP2221056A1/en not_active Withdrawn
- 2002-04-05 DK DK02731267T patent/DK1383508T3/da active
- 2002-04-05 ES ES02731267T patent/ES2266499T3/es not_active Expired - Lifetime
- 2002-04-05 EP EP06076249A patent/EP1712236A3/en not_active Withdrawn
- 2002-04-05 JP JP2002578971A patent/JP2004536046A/ja active Pending
- 2002-04-05 WO PCT/US2002/010747 patent/WO2002080932A1/en not_active Ceased
- 2002-04-05 EP EP02731267A patent/EP1383508B1/en not_active Expired - Lifetime
-
2009
- 2009-12-10 JP JP2009280436A patent/JP2010053155A/ja active Pending
-
2011
- 2011-05-24 JP JP2011115785A patent/JP2011168613A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004536046A5 (enExample) | ||
| JP2005533766A5 (enExample) | ||
| JP2005523313A5 (enExample) | ||
| CA2485677A1 (en) | Methods of treating allergic reactions | |
| JP2023002662A5 (enExample) | ||
| CA2440472A1 (en) | Methods of treating acne | |
| JP2010270124A5 (enExample) | ||
| RU2010140682A (ru) | Способ лечения пациента от инфекции, фармацевтическая композиция (варианты) и лекарственное средство | |
| RU2002101622A (ru) | Нафтохиноновые производные и их использование для лечения и борьбы с туберкулезом | |
| JP2006508128A5 (enExample) | ||
| JP2017537067A5 (enExample) | ||
| JP2020533402A5 (enExample) | ||
| CA2435921A1 (en) | Method of cancer therapy | |
| AU2003226112B9 (en) | Use of non-antibacterial tetracycline analogs and formulations thereof for the treatment of bacterial exotoxins | |
| RU2003126176A (ru) | Кислотно-аддитивные соли тербинафина и яблочной кислоты | |
| JP2005524622A5 (enExample) | ||
| JP2008519848A5 (enExample) | ||
| US20050282786A1 (en) | Method for reducing c-rective protein levels with non-antibacterial tetracycline formulations | |
| CN111655252A (zh) | 含有亚铁氨基酸粒子的组合物及其用于制造治疗或改善胰脏相关疾病的医药品的用途 | |
| RU2007111685A (ru) | Применение 9-оксоакридин-10-уксусной кислоты и/или ее соли в комбинации с антиэстрогеном и/или прогестином для лечения этрогензависимых опухолей, способ лечения и наборы | |
| EP3654988B1 (en) | Sarecycline for the treatment of non-inflammatory acne lesions | |
| RU2019134182A (ru) | Новые способы лечения рассеянного склероза | |
| WO2007075269A2 (en) | Method for inhibiting tooth displacement with non-antibacterial tetracyline formulations | |
| RU2009148830A (ru) | Нерамексан в лечении нистагма | |
| CN1638767A (zh) | 包含埃坡霉素衍生物和烷化剂的组合 |